Names have been removed to protect privacy. Identifying letters are assigned in alphabetical order and bear no relationship to the person’s actual name.
- On 20 June 2022, the Health and Disability Commissioner (HDC) received a complaint from Mr A about the care provided to his wife, Mrs A, by Health New Zealand | Te Whatu Ora Waitematā (Health NZ). The complaint concerns the delayed diagnosis of stroke, the failure to provide appropriate medical treatment, and poor coordination of services.[1]
Information gathered
- Mr A told HDC that, in late October 2021, Mrs A began to experience unusual neurological symptoms, which included recurrent but short-lived episodes of hand weakness, numbness and tingling and, occasionally, speech problems. Mrs A’s general practitioner (GP) at her local medical centre referred her to hospital for assessment of a possible transient ischaemic attack (TIA).[2]
- On 7 December 2021, Mrs A was admitted to Waitākere Hospital with right-handed weakness/sensory changes and dysphasia (speech problems). A neurological examination and head CT scan were normal. The differential diagnoses were documented as ‘ulnar neuropathy,[3] TIAs’. Mrs A was discharged the following day, but no formal follow-up was advised, and the diagnosis at that stage remained unclear. The discharge summary stated that Mrs A’s symptoms were unusual for a stroke or TIA. Health NZ told HDC that, in the absence of persisting symptoms at the time, and with an atypical history/demographic for TIA, usually further investigation would be arranged as an outpatient, but it is not feasible to perform urgent advanced stroke imaging or a neurological consultation with every patient. Health NZ accepted that the lack of further outpatient diagnostic imaging or referral to a neurologist at the time did not meet an appropriate standard of care.
- On 21 January 2022, Mrs A had a consultation with her GP at her local medical centre because she was experiencing ‘fogginess’, dizziness, low mood, and pins and needles in both hands. She was diagnosed with probable vitamin B12 deficiency and prescribed a course of vitamin B12 injections. The GP told HDC that Mrs A’s vitamin B12 levels were checked only after her first vitamin B12 injection.
- On 3 February, Mrs A had a phone consultation with a registered nurse at her local medical centre. Clinical notes of the discussion show that Mrs A reported ongoing numbness in her hand, which had been intermittent since November 2021, and that she had been experiencing slurred speech for one week. The nurse documented that Mrs A did not want to present to the medical centre and did not think her symptoms were serious enough for the Emergency Department (ED). Mrs A was advised to go to the ED if she got worse, and a follow-up appointment was arranged. Mrs A was seen again by her GP on 8 February and 2 March for ongoing neurological symptoms, and a referral was made for Mrs A to be seen in the outpatient neurology service. Mrs A presented to the ED before an appointment could be arranged.
- On 28 February, Mrs A presented to Waitākere Hospital with a COVID-19 infection and fatigue. Mr A told HDC that, because of the COVID-19 restrictions, he had to provide Mrs A’s history to staff and leave her at the door. He said that the history of right-hand weakness, slurred speech, and heavy menstrual bleeding from mid-February were noted by staff, but Mrs A was advised to return home and to take ibuprofen and paracetamol. Health NZ told HDC that Mrs A was advised to follow up with her GP if her symptoms worsened.
- Mrs A re-presented to Waitākere Hospital ED on 5 March with worsening neurological symptoms. Mr A told HDC that Mrs A had developed right-sided weakness and was unable to walk and speak. He said that he explained Mrs A’s symptoms to staff, including that she had been experiencing episodes of difficulty retrieving words, associated with brief seizure activity and two to three minutes of shaking, followed by 15 minutes of grogginess or unresponsiveness, and that these symptoms had been present for some months. Health NZ told HDC that, although neurological symptoms were identified by the ED and general medicine teams on 5 March, a stroke was considered unlikely because of Mrs A’s long history of intermittent neurological episodes and previous normal CT scan results.
- A full detailed history was not obtained until 6 March. Health NZ told HDC that none of the collateral history supported an acute event within the prior 24-hour period, and the normal CT scan of 7 December was ‘genuinely misleading’. In response to the provisional opinion, Mr A told HDC that, when he entered the hospital on 5 March, he told the admitting nurses that he believed Mrs A was having a stroke.
- On 6 March, Mrs A was transferred to [another] Hospital for a neurology assessment and magnetic resonance imaging (MRI) following a normal CT scan. In response to the provisional opinion, Mr A told HDC that Mrs A waited more than 10 hours for a CT scan after her admission on 5 March and that this extensive delay meant any chance of timely intervention was lost.
- Health NZ told HDC that the MRI was unable to be completed that day as Mrs A needed to be ‘cleared’ of COVID-19. In response to the provisional opinion, Mr A said that Health NZ ‘placed greater importance on a faint/residual positive test than on treating [Mrs A’s] obvious and visible neurological symptoms’. Mr A said that the decision to delay urgent imaging in favour of COVID-19 clearance ‘placed procedure above patient safety and directly contributed to harm’.
- Health NZ said that stroke was considered an unlikely diagnosis, and the normal CT imaging was falsely reassuring. Health NZ said that there would have had to have been a clear justification for transferring Mrs A to [another] Hospital on 5 March for an urgent MRI, which on weekends was available only for emergency cases. Health NZ said that Mrs A did not meet this threshold.
- Mrs A was taken out of COVID-19 isolation in the afternoon of 6 March; however, a neurology review (non-contact) was not completed until 9 March.[4] Health NZ agreed that there was a missed opportunity to discuss Mrs A’s presentation with the on-call neurology service on 6 March but that, as an in-person review was not available on the weekend Mrs A presented, a consultation by phone may also not have identified the correct diagnosis.
- The preliminary impression of neurologist Dr B on 9 March was a functional (psychological) neurological disorder. On 10 March, an MRI showed that Mrs A had experienced a stroke. On 3 May, Mrs A was discharged from [another] Hospital (where she had been transferred) following rehabilitation, with a diagnosis of Moyamoya disease.[5] Health NZ told HDC that this is a rare condition and that all clinicians were challenged by the unusual combination of Mrs A’s presenting symptoms, which made proving a diagnosis challenging.
- Health NZ accepted that the stroke diagnosis was delayed by five days and that there was a missed opportunity to perform an MRI scan earlier. Health NZ also accepted that Mrs A was past the mandatory COVID-19 isolation period (10 days) on 6 March. Dr B also stated that he regrets not having assessed Mrs A in person. Health NZ told HDC that it agrees there were opportunities to improve the care provided to Mrs A, but it does not agree that ‘in the complex clinical context of [Mrs A’s] presentation there was a severe departure from established standards of care’.
Changes made
- Health NZ told HDC that, since these events, the regional neurology consulting service at Waitākere Hospital has been increased and improved significantly and is now available Monday to Friday.
Responses to provisional report
Mrs and Mr A
- Mrs and Mr A were given the opportunity to comment on the ‘information gathered’ section of the provisional report. Where relevant, their comments have been incorporated into the final report. In addition, Mr A told HDC:
The repeated delays, dismissals, and prioritisation of process over symptoms all contributed to [Mrs A’s] stroke being diagnosed five days late. These failings had devastating consequences for her long-term health and independence.
Health NZ
- Health NZ was given the opportunity to comment on relevant sections of the provisional report, and it accepted the findings and recommendations made. However, Health NZ also stated:
Mrs A’s delayed diagnosis was not the result of a systems failure or failure to follow appropriate pathways but the result of clinical judgement that ultimately, unfortunately, proved incorrect. Clinical judgement is not infallible, and within the complex clinical context of this presentation that should be acknowledged.
- Dr D from Health NZ said:
I would like to apologise again to Mrs A, her husband and whānau for the distress that this episode has caused. I understand how devastating her illness has been and continues to be and am only sorry for the actions HNZ Waitemata has made that have contributed to making her experience more difficult. I would like to reassure […] [Mr and Mrs A] that HNZ Waitemata takes their experience seriously, and is taking steps to educate the clinical team, to minimise the chance of this situation recurring.
The local medical centre
- The local medical centre was given the opportunity to comment on relevant sections of the provisional report. In response, the medical centre provided some additional information about vitamin B12 deficiencies,[6] including a handout given to patients. The handout states that paradoxical or functional vitamin B12 deficiency occurs when total serum B12 is normal or high, yet metabolic indicators show ‘true intracellular deficiency’. The handout also states: ‘This situation reveals the limitations of using total serum B12 as the sole diagnostic marker’.
Opinion
- As part of my assessment of this complaint, I sought independent clinical advice from general medicine specialist Dr David Cole (Appendix A) and GP Dr Fiona Whitworth (Appendix B).
Health NZ — breach
- Dr Cole noted that TIA was indicated as a differential diagnosis and advised that Mrs A’s symptoms on 7 December were consistent with a TIA or TIA mimic such as a focal seizure. I accept Dr Cole’s advice that, given that TIA was a possibility, it was reasonable to do a CT scan first. However, Dr Cole advised that this is useful only to exclude other pathologies and cannot diagnose a TIA, so further investigation should have been considered and advice sought from a neurologist. Regarding Mrs A’s discharge on 7 December, Dr Cole advised that, if hospital follow-up was not an option, advice should have been provided to Mrs A’s GP about what to do if her symptoms continued. Dr Cole advised that the lack of further investigation of Mrs A’s symptoms and the insufficient follow-up advice provided on 7 December constitute a moderate departure from accepted standards. I accept this advice.
- Dr Cole advised that Mrs A’s symptoms on 5 March were consistent with a stroke and that obtaining a detailed history, preferably by a senior clinician, was critically important. However, it appears that the earliest detailed history was not taken until 16 hours after Mrs A’s presentation to ED. Dr Cole advised that the history that was eventually taken was suggestive of an acute event, and advice should have been sought from a neurologist. Health NZ disagreed that the history and/or symptoms were supportive of an acute event. Health NZ agreed that there was a missed opportunity to discuss Mrs A’s care with the on-call neurology service but said that this may not have assisted in identifying the correct diagnosis. I acknowledge Health NZ’s comments in this respect; however, it is my view that the ambiguity of Mrs A’s symptoms should have prompted a neurology review, irrespective of whether that review would have identified the correct diagnosis. I also note that Dr Cole was mildly critical of the error in the neurology referral which delayed Mrs A’s eventual neurology review by two days.
- Dr Cole also advised that an MRI scan should have been done without delay. He acknowledged the impact of COVID-19 restrictions but considered that guidelines should have been in place to perform necessary radiological interventions safely. He said that diagnostic procedures should not be delayed unless there are exceptional reasons, which there were not in this case. I acknowledge Health NZ’s comments that MRI scanning at [another] Hospital in the weekends was for emergency cases only. However, Mrs A presented to hospital on Saturday 5 March and did not receive an MRI scan until Thursday 10 March. Accordingly, I do not consider the delay in Mrs A receiving an MRI scan to be reasonable in the circumstances and agree with Dr Cole’s advice that this failure constitutes a moderate departure from accepted standards.
- Overall, Dr Cole considered that the care provided to Mrs A during her 5 March presentation constitutes a moderate to severe departure from accepted standards. While I accept Dr Cole’s advice, I also acknowledge Health NZ’s comments that the clinicians were challenged by the ‘unusual constellation of presenting symptoms’, which made a diagnosis challenging, and I accept that this was a mitigating factor in this case.
- Health NZ had a responsibility to provide an appropriate standard of care to Mrs A. Dr Cole has identified deficiencies in the care provided by Health NZ, and I have accepted this advice. Given the number of staff and specialties involved in Mrs A’s care throughout her several presentations to hospital, I consider that these shortcomings are attributable to Health NZ rather than individual clinicians. Accordingly, I find Health NZ in breach of Right 4(1) of the Code of Health and Disability Services Consumers’ Rights (the Code) for failing to provide services to Mrs A with reasonable care and skill.
The local medical centre — adverse comment
- Dr Whitworth advised that overall, the clinical care provided by the GP team at Mrs A’s local medical centre was consistent with good clinical practice. However, she identified two areas where care could be improved.
- Dr Whitworth was mildly to moderately critical that Mrs A’s vitamin B12 levels were not checked prior to her first vitamin B12 injection and that, in the absence of these test results, it is unclear why a diagnosis of vitamin B2 deficiency was made without undertaking a baseline level. In response to the provisional opinion, the local medical centre provided HDC with resources about paradoxical (functional) vitamin B12 deficiency. One of the documents states that paradoxical or functional vitamin B12 deficiency reveals the limitations of using total serum B12 as the sole diagnostic marker. While I acknowledge this further information, a baseline serum B12 level is still an indicator that helps identify or confirm the presence of a deficiency, even though it may only be one of a number of possible diagnostic markers. Accordingly, I agree with Dr Whitworth’s advice and encourage the medical centre and its GPs to reflect on Dr Whitworth’s comments.
- Regarding Mrs A’s call with a medical centre nurse on 3 February, Dr Whitworth is moderately critical that there is no documentation around whether Mrs A was asked to present to either ED or the urgent GP clinic when she was reporting symptoms of ongoing neurological compromise. I accept Dr Whitworth’s advice in this regard and encourage the medical centre to reflect on Dr Whitworth’s comments.
Recommendations
- I recommend that Health NZ provide a written apology to Mrs A for the failings identified in this report. The apology is to be provided to HDC for forwarding, within three weeks of the date of this report.
- I recommend that Health NZ use an anonymised version of this report to conduct training to relevant staff around the presentation and management of TIAs and TIA mimics, safe discharging and safety-netting processes, gathering relevant patient history, and seeking specialist input. Evidence of this training is to be provided to HDC within six months of the date of this report.
- A copy of the final report with details identifying the parties removed, except Health NZ Waitematā, Waitākere Hospital, and my independent advisors, will be placed on the Health and Disability Commissioner website, www.hdc.org.nz, for educational purposes.
Dr Vanessa Caldwell
Deputy Health and Disability Commissioner
Appendix A: Independent clinical advice to Commissioner
The following independent advice was obtained from Dr David Cole, general medicine specialist:
‘Independent clinical advice to Health and Disability Commissioner
|
Complaint: |
[Mrs A] /Health New Zealand Te Whatu Ora Waitematā |
|
Our ref: |
22HDC01497 |
|
Independent advisor:
|
Dr David Cole |
I have been asked to provide clinical advice to HDC on case number 22HDC01497. I have read and agree to follow HDC’s Guidelines for Independent Advisors.
I am not aware of any personal or professional conflicts of interest with any of the parties involved in this complaint.
I am aware that my report should use simple and clear language and explain complex or technical medical terms.
|
Qualifications, training and experience relevant to the area of expertise involved: |
My name is Dr David Cole. I am a Consultant General Physician employed by Health NZ | Te Whatu Ora Waitaha Canterbury, formerly Canterbury District Health Board (DHB).
I graduated from Sheffield University Medical School, England, in 1982 with a Bachelor of Medicine and Surgery awarded with Honours (MB, ChB, Hons). My postgraduate qualifications comprise Membership of the Royal College of Physicians (MRCP, UK), Doctor of Medicine (MD, Sheffield University) and Fellowship of the Royal Australasian College of Physicians (FRACP). I have sub-specialty interests in endocrinology, diabetes and obstetric medicine. I am an honorary Clinical Senior Lecturer at the University of Otago. |
|
Documents provided by HDC: |
|
|
Referral instructions from HDC: |
Health New Zealand | Te Whatu Ora Waitematā
|
Factual summary of clinical care provided complaint:
Appendix B: Internal clinical advice to Commissioner
The following internal advice was obtained from general practitioner Dr Fiona Whitworth:
‘CLINICAL ADVICE — MEDICAL
FROM : Dr Fiona Whitworth
CONSUMER : [Mrs A]
PROVIDER : [The local medical centre]
FILE NUMBER : C22HDC01497
DATE : 7/10/2024
1. My name is Dr Fiona Whitworth. I am a graduate of Oxford University Medical School, and I am a practising general practitioner. My qualifications are: MA 1991, BM BCh 1994, DCH 1996, DCRCOG 1996, MRCGP 1999, PGCMed Ed 2011, FRNZCGP 2013, PGDip GP 2016, FAEG 2020. Thank you for the request that I provide clinical advice in relation to the complaint from [Mr A] about the care provided by Waitākere Hospital and [another] Hospital. In preparing the advice on this case, to the best of my knowledge I have no personal or professional conflict of interest. I agree to follow the Commissioner’s Guidelines for Independent Advisors.
I have been asked to provide a steer on whether the care provided by [the local medical centre] was appropriate between December 2021 and March 2022 (inclusive) and what departures, if any, may have been made.
2. Documents reviewed.
10/9/2024 GP notes and response [by the local medical centre]
3. Provider response(s)
[The medical centre] has provided a full set of GP notes. They have not, however, been asked to comment on the care provided so this has not been submitted. Without this, some of the clinical reasoning may be unclear (treatment of vit b12).
4. Clinical Steer
Overall, the clinical care provided by the GP team was consistent with good clinical practice.
However, I am moderately critical that it is not documented whether [Mrs A] was asked (or not) to attend ED or the urgent GP clinic on 3/2/2022 as a matter of urgency when she had a telephone call to the nurse at the clinic. She was presenting with features of ongoing neurological compromise — possible crescendo TIA/CVA [cerebrovascular accident].
Regarding the use of tranexamic acid:
Tranexamic acid is contraindicated “active thromboembolic disease, or history of thromboembolic disease unless treated”.[7]
However, when initiated by the GP on 2/3/2022 there had been no diagnosis of active or previous thromboembolic disease. I am therefore not critical of its use at this time. The doctor did additionally check both a D-dimer and coagulation screen. It is unclear why this was started in hospital when a CVA had been confirmed — I note this was not continued on discharge and its use had controlled [Mrs A’s] menstrual loss.
5. Clinical Timeline and Comments
PMH
25/5/2022 Moyamoya-like occlusive vasculopathy.
2012 Ectopic pregnancy right salpingectomy and left Tubal Ligation
1/10/2019 Mirena inserted.
7/12/2021 GP Consultation Dr […]
45 yr old noted to have intermittent left-hand weakness 5–6 times per week and has to use other hand to hold it. Also noted to have speech changes at the same time “hard to get words out of her mouth”. She was noted to be an ex-smoker and FH father MI aged 53.
Examination — normal neurological examination and gait.
A diagnosis of possible TIA was made, and she was admitted to Waitākere Hospital for review.
Comment
This is acceptable GP clinical practice with identification of possible disease and transfer to secondary care. The referral letter is clear.
7/12/2021 Waitākere Hospital admission
Right-hand weakness but normal neurological examination CT head normal. No CT angiogram completed at this time. No antiplatelet medication commenced.
The diagnosis was unclear.
21/1/2022 GP Consultation Dr […]
It is documented that she presented with “fogginess, dizziness, low mood, pins and needles both hands. No period 2/12, had tubal ligation”.
She was diagnosed with probable vit b12 deficiency and a course of replacement injections given. Blood tests were ordered.
Comment
It is not clear whether the bloods were done before the nurse gave the vit b12 injection. I am unclear as to why a definitive diagnosis has been made without the blood results. On notes review, there were no recent previous vit b12 levels undertaken. I am mildly critical that the tests were not completed prior to the injection regimen being started. However, this does not impact on her later clinical trajectory.
The panel of blood tests are appropriate.
Vit B12 >1470 — implying bloods taken after the injection.
TC 5.2mmol/l; ldl 3.3 mmol/l
Kidney function normal
Hba1c normal — no diabetes
21/1/2023 Nurse Clinic
Vit b12 given.
28/1/2023 Nurse Clinic
Vit b12 given.
3/2/2022 Phone call to Nurse-led Clinic.
It is documented that she reported ongoing numbness — R>L hand that had been intermittent since November 2021. It was also noted that she was presenting with slurred speech for 1 week and that her family were noticing this more.
It is documented that she is struggling to get words out. It is documented that she “doesn’t want to come into [clinic], doesn’t think acute enough for ED”. She was advised to go to ED if worse over the weekend and appointment made for the week for review.
Comment
I am moderately critical that she was not asked to attend ED or the urgent GP clinic with this presentation of ongoing neurological compromise — possible crescendo TIA / CVA.
8/2/2022 GP Consultation Dr […]
It is documented that there is a history since Nov 21 of intermittent neurological symptoms — slurred speech and weakness/tingling upper limbs — mainly affecting right hand. The speech disturbance was thought to be more dysarthria.
On the morning of presentation, she had had left-hand weakness. It was noted that she was concerned about temporal sequence from COVID vaccination.
Examination Cranial nerve, speech upper limb and cerebellar testing normal.
A diagnosis of new MS was considered. She was referred to neurology for consideration of MRI and return advice given.
Referral sent that day and triaged as P3 — see inside 8 weeks.
Comment
The actions are consistent with standard general practice care. However, another option would have also been to have discussed her care with the on-call medical team for advice.
2/3/2022 Telephone consultation Dr […]
Noted to be COVID positive. She has had a 2-week period and passed out after feeling hot and sweaty, noted to have numb hands. It is documented there was no shaking but that her eyes rolled back and teeth were grinding. There was no documented post-ictal phase. There were specifically no issues with speech or weakness in arms and legs.
A diagnosis of Loss of consciousness ? vasovagal was made. Safety-netting advice was given, and she was sent for bloods: FBC, D-dimer, coagulation, CRP, and ferritin.
She was prescribed tranexamic acid 1g tds [three times daily] for up to 4 days when menstruation has started.
Comment
The clinical diagnosis of a syncopal episode is reasonable. As she was COVID positive, it was reasonable to not see her in clinic at this time but to give safety-netting advice.
Heavy periods can contribute to syncope, and therefore the use of tranexamic acid was not unreasonable and is part of the Health pathways abnormal uterine bleeding pathway.[8] The GP has checked for underlying clotting issues and also done appropriate baseline tests. It is not clear what information was given re side effects of tranexamic acid.
2/3/2022 Telephone consultation Dr […]
Discussion re tranexamic acid use and clotting. Noted that she is COVID positive and advice given to start medication after the result of D-dimer is available.
5/3/2022 Waitematā Hospital admission
Episodic left MCA hypoperfusion with limb-shaking TIA since November progressing to left MCA infarction. Noted to have also bilateral multifocal intracranial stenoses. ? cause.
Also noted to have heavy menstrual bleeding
6/3/2022 CT head normal
10/3/2022 MRI head subacute large left MCA territory infarction secondary to occlusion of proximal left MCA.
CTP — showed proximal left MCA occlusion — advised an established infarct and not for clot removal — aspirin started.
Neurology involved.
Telemetry 24 h nad.
Heavy bleeding noted — admission Hb 84 iv ferrinject given in ED. Gynaecology registrar recommended referral for pelvic ultrasound as an outpatient. Tranexamic acid started, which improved bleeding.
An inpatient pelvic ultrasound thickened endometrium and adenomyosis not excluded. Gynaecology team advised blood transfusion and addition of Provera 20mg od and referral to OPD gynaecology (noted this is safe in acute stroke).
It is later stated that not for tranexamic acid given acute stroke.
She was transferred to [another hospital] for further management.
8/3/2022 Telephone consultation Dr […]
Conversation is with husband. It is noted that she was admitted on 6/3/22 with symptoms of a stroke (aphasia, left facial droop and right-body weakness) but that a CT scan head was normal. That she was awaiting an MRI head. It is stated that she deteriorated on day 8 of COVID-19 infection.
The thought was of a complication of COVID-19 with CVA.
7/3/2022 Decline from gynaecology — request for community-based ultrasound and treatment pathway. Re heavy menstrual bleeding.
11/3/2022 Referral to gynaecology re heavy menstrual bleeding
15/3/2022 Cerebral angiogram
Bilateral anterior circulation intracranial vasculopathy with a Moyamoya-type pattern, of uncertain aetiology.
Addendum to report 7/4/2025
I note the email response from Dr […] 12/3/2025.
This recounts the clinical history. It notes that vit b12 levels were checked after the first injection.
It is therefore still unclear as to why a diagnosis of vit b12 deficiency was made without undertaking a baseline level.
I am mild to moderately critical of this omission.
The reply does not otherwise change my previous advice.’
[1] Mr and Mrs A believe that the COVID-19 vaccine was the underlying cause of Mrs A’s health issues. Mr A said that the symptoms began shortly after Mrs A was vaccinated, and it is their view that the vaccine was likely responsible for the vascular disease that caused the stroke.
[2] A TIA is a mini stroke. Unlike a stroke, TIAs are brief and resolve fully. However, TIAs can be a warning of an imminent stroke.
[3] A weakness of the ulnar nerve.
[4] Health NZ told HDC that the review was meant to occur on 7 March, but the referral form recorded that Mrs A was in Waitākere Hospital rather than [another] Hospital. Accordingly, a new referral had to be completed.
[5] A rare, progressive cerebrovascular disorder caused by blocked arteries at the base of the brain in an area called the basal ganglia.
[6] See the journal article about paradoxical vitamin B12 deficiency at https://www.iomcworld.org/articles/paradoxical-vitamin-b12-deficiency-normal-to-elevated-serum-b12-with-metabolic-vitamin-b12-deficiency-91903.html.